Ohio State-led study links protein, clusterin, to cardiac and metabolic diseases
During a study spanning nearly a decade, researchers at The Ohio State University College of Medicine, Houston Methodist Research Institute and Houston Methodist Cancer Center have linked the protein clusterin — for the first time — to many different facets of cardiometabolic syndrome risk through its actions in the liver. Cardiometabolic syndrome (CMS) is a cluster of conditions occurring together that increase a person’s risk of heart disease, stroke and diabetes.
Go to Source
